63200 Life Elixir: how a pharmaceutical company launched the production of infusions And why is it unique for Ukraine. Pavlo Harlamov - 10 may 2018
65637 Medical investment: where Ukrainian pharmacy needs support What factors can attract foreign capital into the industry Katerina Grebenik - 25 april 2018
55153 The story of recovery: how the Ukrainian pharmaceutical market is getting over the crisis For the first time in four years, sales growth in monetary terms has been recorded Viktoriya Pokatis - 19 april 2018
45939 General director of pharmaceutical firm “Darnitsa”: “Import substitution is nothing more than another form of competition” Svitlana Didenko speaks about market realities, public interests, patients’ preferences and the company’s readiness for the healthcare reform 5 april 2018
63200 Life Elixir: how a pharmaceutical company launched the production of infusions And why is it unique for Ukraine. Pavlo Harlamov, Viktor Gacenko - 10 may 2018
65637 Medical investment: where Ukrainian pharmacy needs support What factors can attract foreign capital into the industry Katerina Grebenik - 25 april 2018
55153 The story of recovery: how the Ukrainian pharmaceutical market is getting over the crisis For the first time in four years, sales growth in monetary terms has been recorded Viktoriya Pokatis - 19 april 2018
45939 General director of pharmaceutical firm “Darnitsa”: “Import substitution is nothing more than another form of competition” Svitlana Didenko speaks about market realities, public interests, patients’ preferences and the company’s readiness for the healthcare reform 5 april 2018